Morpho Sys AG

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 4132
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 220
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9404929 Methods for identification of an antibody or a targetFeb 11, 09Aug 02, 16[C12N, G01N]
9243066 Use of M-CSF antibodies in the treatment of osteoarthritis or painJul 17, 12Jan 26, 16[A61K, C07K]
9238689 Antibodies that are cross-reactive for macrophage migration inhibitory factor (MIF) and D-dopachrome tautomerase (D-DT)Jul 13, 12Jan 19, 16[A61K, C07K]
9200061 Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3iNov 22, 11Dec 01, 15[A61K, C12N, C07K]
9062097 Methods for the formation of disulphide bondsAug 21, 08Jun 23, 15[C12N, C40B, C07K]
8759087 InternalizationDec 12, 07Jun 24, 14[C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8551920 Libraries and methods for isolating antibodiesExpiredFeb 01, 06Oct 08, 13[C40B]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.